Novel sensing mechanism discovered in dendritic cells to increase immune response to HIV

September 8, 2010, New York University School of Medicine
HIV-1 viral particles, shown here as dark spheres, are recognized by infected human dendritic cells, the sentinels of the immune system, through a newly discovered sensor. The viruses are then released in special packets that are presented to T-cells to indicate which invaders the T-cell army should attack. Manipulating this novel response system could aid in vaccine design, a new study shows. Credit: Credit: Nicolas Manel, Alice Liang and Eric Roth

Dendritic cells are the grand sentinels of the immune system, standing guard 24/7 to detect foreign invaders such as viruses and bacteria, and bring news of the invasion to other immune cells to marshal an attack. These sentinels, however, nearly always fail to respond adequately to HIV, the virus causing AIDS. Now a team of scientists at NYU Langone Medical Center has discovered a sensor in dendritic cells that recognizes HIV, spurring a more potent immune response by the sentinels to the virus. They report their findings in the September 9, 2010, issue of Nature.

"This is the first time that an alarm system that recognizes retroviruses like HIV has been discovered," says Dan Littman, MD, PhD, the Helen L. and Martin S. Kimmel Professor of in the Departments of Pathology and Microbiology at NYU Langone Medical Center and a Howard Hughes Medical Institute investigator, and the study's lead author.

"The ability to stimulate a protective against HIV is critical to the development of therapeutic or preventive vaccines for the virus," says Dr. Littman. In contrast to normal vaccines, which prevent infection, therapeutic vaccines are designed to boost the severely weakened immune systems of people infected with HIV.

Dendritic cells, named for their branching, tree-like shape, have been called the maestros of the because they orchestrate a dynamic range of immune responses. These cells have attracted intense interest from researchers in many fields because of their potential to fight disease and prevent rejection of organ transplants.

When a dendritic cell captures a dangerous pathogen, it tears it apart and delivers a piece to the soldiers of the immune system cells, called T-cells, which in turn expand like a clonal army to coordinate immune defenses and destroy the invader. But dendritic cells fail to recognize HIV as a danger. Instead, HIV exploits the cells to get a free ride to T-cells, which become infected with the virus. "The virus actually infects the same soldiers that are supposed to protect us from it," explains co-author Derya Unutmaz, MD, associate professor in the Departments of Microbiology, Pathology and Medicine at NYU Langone Medical Center.

Although HIV enters dendritic cells, an unknown mechanism blocks the virus from infecting them—going into the nucleus of the cells to make copies of itself. Recently, a technique was discovered to overcome this block by bathing the cells with a protein derived from SIV, a relative of HIV that only infects monkeys. Using these techniques, the researchers discovered that when HIV was forced to enter the nucleus of , the cells unexpectedly recognized the virus as an intruder and went into action to initiate a program to stimulate a stronger T-cell response against the virus.

What set off the alarm, the researchers found, was a protein called capsid, which encapsulates HIV's genetic material. "It's surprisingly unexpected that the sensing mechanism of the dendritic cell recognizes the capsid of the virus, rather than the genetic material inside," says co-author Nicolas Manel, PhD, of The Kimmel Center for Biology and Medicine at the Skirball Institute at NYU Langone Medical Center and the Institut de Genetique Moleculaire de Montpellier. "Nevertheless, by adding elements of this capsid to a vaccine," says Dr. Manel, "it may be possible to improve the immune response of those who already have HIV or actually mount a potent immune response before the individual is infected."

"We still don't understand why this sensor is triggered only when we force HIV to integrate into dendritic cell genome to make its own copies," adds Dr. Unutmaz. "One possibility is that this cryptic sensing mechanism has evolved to recognize the thousands of ancient retroviruses that have infected us in the past and now make up almost 10% our genome. It is conceivable that dendritic have evolved this internal sensor in case any of these archaic retroviruses were reawakened. Nonetheless, the finding is extremely exciting because not only it could lead to new directions in vaccine research but it can also be exploited to enhance vaccines against other viruses."

Related Stories

Recommended for you

HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection

January 18, 2018
A first-of-its-kind study has found that the genetic diversity of human immunodeficiency virus type 1 (HIV-1) is higher in the vaginal tract than in the blood stream during early infection. This finding, published in PLOS ...

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

gmurphy
not rated yet Sep 08, 2010
While this is some outstanding research, it makes me a little uneasy to think that their strategy is to "mix in bits" of the capsid to see if provokes a reaction, although, I perfectly willing to concede that this uneasiness arises from my broad ignorance of the subject matter.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.